These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3542453)

  • 21. Comparison of subcutaneous soluble human insulin and insulin analogues (AspB9, GluB27; AspB10; AspB28) on meal-related plasma glucose excursions in type I diabetic subjects.
    Kang S; Creagh FM; Peters JR; Brange J; Vølund A; Owens DR
    Diabetes Care; 1991 Jul; 14(7):571-7. PubMed ID: 1914797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The absorption of short-acting insulin administered subcutaneously in diabetic patients].
    Nakamura T; Sekino K; Kasai F; Ishii F; Kudoo M; Imamura K; Kikuchi N; Takebe K
    Probl Endokrinol (Mosk); 1993; 39(2):14-6. PubMed ID: 8016042
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of insulin levels after injection by jet stream and disposable insulin syringe.
    Malone JI; Lowitt S; Grove NP; Shah SC
    Diabetes Care; 1986; 9(6):637-40. PubMed ID: 3542456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The importance of the time interval between insulin injection and breakfast in determining postprandial glycaemic control--a comparison between human and porcine insulin.
    Patrick AW; Collier A; Matthews DM; Macintyre CC; Clarke BF
    Diabet Med; 1988 Jan; 5(1):32-5. PubMed ID: 2964325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Miscibility of semisynthetic human ultralente insulin with short-acting insulin in insulin-dependent diabetic patients.
    Lunetta M; di Mauro M; Crimi S; Sudano L; Mughini L
    Acta Diabetol Lat; 1988; 25(3):263-9. PubMed ID: 3071068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of insulin analogue B9AspB27Glu and soluble human insulin in insulin-treated diabetes.
    Kang S; Owens DR; Vora JP; Brange J
    Lancet; 1990 Feb; 335(8685):303-6. PubMed ID: 1967767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intramuscular versus subcutaneous injection of unmodified insulin: consequences for blood glucose control in patients with type 1 diabetes mellitus.
    Vaag A; Pedersen KD; Lauritzen M; Hildebrandt P; Beck-Nielsen H
    Diabet Med; 1990 May; 7(4):335-42. PubMed ID: 2140087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variability of insulin absorption and insulin action.
    Heinemann L
    Diabetes Technol Ther; 2002; 4(5):673-82. PubMed ID: 12450450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of twice daily regimens of Actrapid and Monotard insulins.
    Akintewe TA
    East Afr Med J; 1985 Mar; 62(3):196-9. PubMed ID: 3893969
    [No Abstract]   [Full Text] [Related]  

  • 30. Insulin administered intranasally as an insulin-bile salt aerosol. Effectiveness and reproducibility in normal and diabetic subjects.
    Moses AC; Gordon GS; Carey MC; Flier JS
    Diabetes; 1983 Nov; 32(11):1040-7. PubMed ID: 6357902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin bolus given by sprinkler needle: effect on absorption and glycaemic response to a meal.
    Edsberg B; Herly D; Hildebrandt P; Kühl C
    Br Med J (Clin Res Ed); 1987 May; 294(6584):1373-6. PubMed ID: 3109661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucose-lowering effect of insulin by different routes in obese and lean nonketotic diabetic patients.
    Shahshahani MN; Kitabchi
    J Clin Endocrinol Metab; 1978 Jul; 47(1):34-40. PubMed ID: 400713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients.
    Bruttomesso D; Pianta A; Mari A; Valerio A; Marescotti MC; Avogaro A; Tiengo A; Del Prato S
    Diabetes; 1999 Jan; 48(1):99-105. PubMed ID: 9892228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical pharmacokinetics and pharmacodynamics of insulin lispro mixtures.
    Roach P; Woodworth JR
    Clin Pharmacokinet; 2002; 41(13):1043-57. PubMed ID: 12403642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incorporating a generic model of subcutaneous insulin absorption into the AIDA v4 diabetes simulator. 3. Early plasma insulin determinations.
    Lehmann ED; Tarín C; Bondia J; Teufel E; Deutsch T
    J Diabetes Sci Technol; 2009 Jan; 3(1):190-201. PubMed ID: 20046665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacology of a 40 IU/ml porcine lente insulin preparation in diabetic cats: findings during the first week and after 5 or 9 weeks of therapy.
    Martin GJ; Rand JS
    J Feline Med Surg; 2001 Mar; 3(1):23-30. PubMed ID: 11716627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma free insulin profiles after administration of insulin by jet and conventional syringe injection.
    Taylor R; Home PD; Alberti KG
    Diabetes Care; 1981; 4(3):377-9. PubMed ID: 7047114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overnight interruption of wearing insulin pump: substitution dose and injection site of insulin.
    Helve E; Pelkonen R; Koivisto VA
    Diabetes Care; 1986; 9(6):565-9. PubMed ID: 3542449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nighttime insulin kinetics and glycemic control in type 1 diabetes patients following administration of an intermediate-acting lispro preparation.
    Janssen MM; Casteleijn S; Devillé W; Popp-Snijders C; Roach P; Heine RJ
    Diabetes Care; 1997 Dec; 20(12):1870-3. PubMed ID: 9405909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.